التفاصيل البيبلوغرافية
| العنوان: |
Potential effect of new (E)‐4‐hydroxy ‐N'‐(1‐(7‐hydroxy‐2‐oxo‐2H‐chromen‐3‐yl) ethylidene) benzohydrazide against acute myocardial infarction: Haemodynamic, biochemical and histological studies |
| المؤلفون: |
Mnafgui, Kais, Khdhiri, Emna, Hajji, Raouf, Feriani, Anouar, Ivan da Silva, Francisco, Laíres da Silva Santos, Antônia, Tlili, Abir, Mlayeh, Souhail, Bouzidi, Moncef, Ammar, Houcine, Abid, Souhir |
| المصدر: |
Clinical & Experimental Pharmacology & Physiology; Jan2021, Vol. 48 Issue 1, p107-120, 14p, 2 Color Photographs, 3 Diagrams, 9 Charts, 6 Graphs |
| مصطلحات موضوعية: |
PROTEIN disulfide isomerase, HEMODYNAMICS, HEART diseases, ANGIOTENSIN converting enzyme, CARDIAC hypertrophy, MYOCARDIAL infarction, MYOCARDIUM |
| مستخلص: |
This study aimed to explore the cardioprotective effect of new synthesized coumarin (E)‐4‐hydroxy‐N'‐(1‐(7‐hydroxy‐2‐oxo‐2H‐chromen‐3‐yl) ethylidene) benzohydrazide denoted (Hyd.Cou) against myocardial infarction disorders. Male Wistar rats were divided into four groups; Control, isoproterenol (ISO), ISO + Acenocoumarol (Ac) and ISO + Hyd.Cou. Results showed that the ISO group exhibited serious alteration in EGC pattern, significant heart hypertrophy (+33%), haemodynamic disturbance and increase in plasma rate of CK‐MB, LDH and troponin‐T by 44, 53, and 170%, respectively, as compared to Control. Moreover, isoproterenol induced a rise in plasma angiotensin‐converting enzyme activity (ACE) by 49%, dyslipidaemia, and increased thiobarbituric acid‐reactive substances (TBARS) by 117% associated with decrease in the activity of superoxide dismutase (SOD) and glutathione peroxidase (GPx) by 46% and 58%, respectively in myocardium. Interestingly, the molecular docking calculation demonstrated strong interactions of Hyd.Cou with the receptors of the protein disulphide isomerase (PDI) which could highlight the antithrombotic effect. Moreover, Hyd.Cou improved plasma cardiac dysfunction biomarkers, mitigated the ventricle remodelling process and alleviated heart oxidative stress damage. Overall, Hyd.Cou prevented the heart from the remodelling process through inhibition of ACE activity and oxidative stress improvement. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical & Experimental Pharmacology & Physiology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
